The kind of clients Markus works with ranges from single inventors to large-scale enterprises. Besides drafting of patent applications and prosecution, Markus offers guidance to his clients in terms of patent portfolio management and litigation strategies.
Markus advises his clients in the fields of trade mark and design law.
Before starting in a large Munich patent law firm he worked in a patent law firm in New York City.
Markus holds a Bachelor and Master’s degree of Science in molecular Biotechnology at the Technical University in Munich. During his studies Markus worked at the University of Amsterdam and studied one semester at the Nanyang Technological University in Singapore. After three years of research at the Max-Planck Institute for Infectious Biology in Berlin he received his Doctor’s degree in the field of molecular biology, especially (auto) antibodies.
Markus is a Patentanwalt (German Patent Attorney), European Patent Attorney as well as European Trade Mark and Design Attorney.
BSc in Science
MSc in Science
PHD in Immunobiology
January 29th 2020
October 18th 2018
Markus is providing training sessions to German Patent and Trade Mark Attorney and European Patent Attorney Trainees and also to support staff.
Further, he is a member of the examination board for German patent paralegals (Patentanwaltsfachangestellte).
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Innovation in medical devices continues strongly and the introduction of IoT and 3D printing (amongst others) has led to an acceleration in new medical devices. Whilst patents and designs are …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
The HGF European team will be attending the INTA 2022 Annual Meeting Live+. It is being held on 30th April – 4th May in Washington, D.C. INTA brings together the …Event details
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.